
Sarepta Therapeutics
Sarepta is a biotechnology company on an urgent mission to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs) and have 40+ programs in development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
Organisation size: Large (500 – 4999)
Sector: Healthcare / Life Sciences
Website: www.sarepta.com

2025 Accolades
Submission highlights
This year’s strongest elements as indicated by our independent judges.
-
Employee Voice